Evidence map›Paper›PMID 12917624›Full record

ArticleOncogene2003

SUV39H1 interacts with AML1 and abrogates AML1 transactivity. AML1 is methylated in vivo.

Soumen Chakraborty, Kislay Kumar Sinha, Vitalyi Senyuk, Giuseppina Nucifora

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Interactions and Feedbacks in E-Cadherin Transcriptional Regulation.Frontiers in cell and developmental biology · 2021
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Soumen ChakrabortyDepartment of Pathology and The Cancer Center, University of Illinois at Chicago, Chicago, IL 60607, USA.
Kislay Kumar Sinha
Vitalyi Senyuk
Giuseppina Nucifora
University of Illinois Chicago · US

Funding

Role of EVI1 Modifications in Cell TransformationR01CA096448 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NUCIFORA, GIUSEPPINA · 2001 to 2009
$2.6M
MOLECULAR ANALYSIS OF TEL AND TEL/AML1 IN PREB LEUKEMIAR01CA072675 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NUCIFORA, GIUSEPPINA · 1997 to 2001
$495k
NCI NIH HHS CA72675NCI NIH HHS CA96448
6 · The paper itself

Abstract

Acute myeloid leukemia 1 (AML1) belongs to a family of DNA-binding proteins highly conserved through evolution. AML1 regulates the expression of several hematopoietic genes and is essential for murine fetal liver hematopoiesis. We report here that the histone methyltransferase SUV39H1, a mammalian ortholog of the Drosophila melanogaster SU(VAR) 3-9, forms complex with AML1. SUV39H1 methylates lysine 9 of the histone protein H3 leading to the formation of the high-affinity binding site on chromatin for proteins of the heterochromatin protein 1 family (HP1). The interaction of AML1 with SUV39H1 requires the N-terminus of AML1 where the Runt domain is located. Binding of AML1 to SUV39H1 abrogates the transactivating and DNA-binding properties of AML1 and dissociates the net-like nuclear structure of AML1. It has been reported that AML1 is capable of interaction with histone acetyl transferases (CBP, p300, and MOZ) and with component of the histone deacetylase complex (Sin3), and that the interaction with these coregulators affects the strength of AML1 in promoter regulation. Our data suggest that other enzymes are also involved in gene regulation by AML1 activity by modulating the affinity of AML1 for DNA.

Indexed as

Proto-Oncogene Proteins3T3 CellsAnimalsCore Binding Factor Alpha 2 SubunitDNADNA-Binding ProteinsMethylationMethyltransferasesMicePromoter Regions, GeneticProtein BindingReceptor, Macrophage Colony-Stimulating FactorRepressor ProteinsTranscription FactorsCore Binding Factor Alpha 2 SubunitDNADNA-Binding ProteinsMethyltransferasesProto-Oncogene ProteinsReceptor, Macrophage Colony-Stimulating FactorRepressor ProteinsRunx1 protein, mouseSuv39h1 protein, mouseTranscription Factors

Identifiers

PMID12917624
OpenAlexW2068160448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.